Sign in
HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL
Journal article   Open access   Peer reviewed

HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL

M. Shadman, C. Yeung, M. Redman, S. Y. Lee, D. H. Lee, D. H. Qian, S. Ra, C. S. Ujjani, B. J. Dezube, E. H. Warren, …
Hematological oncology, Vol.41(S2), pp.87-88
2023-06
url
https://doi.org/10.1002/hon.3163_49View
Published (Version of record) Open

Details